Growth and new partnerships have Glytec excited for the future of its Glucommander insulin dosing decision support software.
After years of running a hospitalist group and mentoring hospitals on quality improvement, blood clot prevention and more, Dr. Jordan Messler found himself falling into a lot of work on diabetes.
Messler cut his teeth on quality improvement around diabetes, observing that inpatient glycemia impacts about 40%-50% of patients in the hospital. That work brought him to Glytec, where he now serves as chief medical officer.
“The work that I’ve done in quality improvement around glycemic control has been to help to standardize care,” Messler told Drug Delivery Business News. “We know what best practices are to manage diabetes in the hospital and, largely, that revolves around insulin.”
Get the full story at our sister site, Drug Delivery Business News.